WeChat Mini Program
Old Version Features

MA15.11 Neoadjuvant Sintilimab Plus Chemotherapy in EGFR-mutant NSCLC Followed by Adjuvant Osimertinib or Observation: A Phase II CTONG2104 Trial

Journal of Thoracic Oncology(2024)

Cited 0|Views1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined